Prostate.Carcinoma.ai
Diagnostic and Therapy
Information
We want to reduce misdiagnosis and increase reporting efficiency in radiology
with Artificial Intelligence.
To this purpose, FUSE-AI has developed a robust AI backbone in the last few years.
This should be seen like an engine room that handles all processes starting from data pre-processing to disease prediction. Based on this, we have successfully developed our first product for radiologists named "Prostate.Carcinoma.ai". This AI software is intended to support radiologists in reducing misdiagnoses.
Prostate.Carcinoma.ai successfully segments and detects suspicious areas in the prostate on MRI
images and will be released as a medical product to all PACS providers for the European market.
Development of medical software and apps according to regulatory requirements
The German Federal Institute for Drugs and Medical Devices (BfArM) lists FUSE-AI as an official
'Software as a Medical Device' (SaaMD) developer and distributor in Europe. Concerning software
development, our competences are based on
1. intelligent image analysis using Deep Learning and Machine Learning methods
2. image registration, classification software and interface engineering
3. app development
FUSE-AI consults companies for software development as medical devices in compliance with the required standards according to MDM and MDR IIa (CE).
